+629.1%
MRNA vs RGEN
+167.4%
+461.7%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | RGEN | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -2.1% | -1.3% | -2.4% |
| 7D | -10.1% | -4.6% | -5.5% | -8.2% |
| 30D | +126.7% | +1.2% | +125.6% | +128.0% |
| 3M | +184.1% | +26.8% | +157.3% | +159.4% |
| 6M | +143.3% | +29.1% | +114.2% | +118.4% |
| YTD | +359.9% | +0.7% | +359.1% | +356.7% |
| 1Y | +454.2% | +39.1% | +415.1% | +384.2% |
| 3Y | +26.0% | +2.2% | +23.7% | +17.0% |
| 5Y | -70.3% | -44.0% | -26.3% | -67.9% |
| All | +629.1% | +167.4% | +461.7% | +484.1% |
Cumulative growth
Daily Returns
Daily percentage return beside RGEN.
Daily Out/Under-Performance
Portfolio return minus RGEN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RGEN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded RGEN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling